NLR, PLR, and HPR as novel diagnostic biomarkers for Acute Lymphoblastic Leukemia
نویسندگان
1 Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
2 Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
3 Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
4 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iranian Blood Transfusion Organization (IBTO), Tehran, Iran
5 Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
6 Department of Pathology, Faculty of Medicine, University of Medical Sciences, Mashhad, Iran
7 Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
8 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iranian Blood Transfusion Organization (IBTO), Tehran, Iran
doi
10.58209/ijbc.15.2.80چکیده
Background: Acute lymphoblastic leukemia (ALL) causes uncontrolled cell proliferation and prevents normal cell differentiation at any stage of hematopoiesis. Therefore, timely diagnosis and treatment are very important. Complete blood count (CBC) can be a simple, but valuable initial test to diagnose ALL. In this study, we investigated the diagnostic value of ...
